Malassezia yeasts are commensals of normal human skin, but also cause pityriasis versicolor, seborrhoeic dermatitis and evidence is accumulating that they play a significant role in atopic eczema/dermatitis syndrome (AEDS; formerly atopic dermatitis). The taxonomy of the genus has changed considerably and is likely to change more in the future. Our understanding of the interaction between Malassezia and the host demonstrates that it has the paradoxical ability to both stimulate and suppress the immune response directed against it and there is a fine balance in its existence at the interface between commensalism and pathogenicity.
similar colour in vitro [17] . Further properties of these alkaloids also seem to correlate with other clinical signs of pityriasis versicolor. Malassezin induces apoptosis of melanocytes, leading to decreased melanin synthesis which may contribute to the depigmentation of lesions of pityriasis versicolor in some patients [18] . Pityriarubins are inhibitors of the respiratory burst and have been suggested as being partially responsible for the limited inflammatory response seen in lesions of pityriasis versicolor [19] .
For organisms such as Malassezia that live as commensals, protective mechanisms against host defences are very important in enabling them to survive in their normal environment. Recently, the presence of melanin-like pigment in the yeast in vitro and in vivo in pityriasis versicolor and seborrhoeic dermatitis lesions has been reported [20] . Melanized fungi are less susceptible to reactive oxygen species generated during immunological responses and production of melanin is known to be an important virulence factor for Cryptococcus [21] . Malassezia , another pathogenic basidiomycetous yeast, may therefore employ a similar mechanism of protection against the host defences.
Malassezia species produce a wide range of enzymes, including lipases, phospholipases and a hydrolase. The lipases are essential in providing the lipids required for growth and recently the gene encoding an extracellular lipase in M. furfur was expressed and the lipase characterized [22] . The gene, MfLIP1, encoded a protein with a molecular mass of 54.3 kDa and a pH optimum of 5.8 with hydrolytic activity against Tweens, often used in culture media as a lipid source. Flanking MfLIP1 was a gene encoding catalase, which may also be secreted by the organism. Another enzyme with lipolytic activity and homology to the lipases of Candida has been described in M. pachydermatis [23] . The enzyme had a predicted molecular mass of 48 kDa, was produced when the organism was grown without lipids in the culture medium and contained a consensus sequence which is conserved among lipolytic enzymes. The pH optimum was 7.5 and the enzyme was most active against substrates with a carbon chain length of C 8. In vitro Phospholipase A 2 activity by Malassezia is able to release arachidonic acid from epithelial cells which has been postulated as an initiator of the inflammatory response in the skin seen in Malassezia -associated diseases [24] .
Taxonomy
The taxonomy of Malassezia has undergone extensive revisions in the last 10 years and is still in a state of flux, with a new species described but not formally recognized (M. equi [25] ) and other species demonstrating significant diversity [26, 27] . Eichstedt was the first to describe a fungus associated with lesions of pityriasis versicolor in 1846 (cited by [28] ), although it was not until 1853 that the organism was named Microsporon furfur. The yeast phase was named Pityrosporum , with three species recognized Á P. orbiculare, P.ovale and P. pachydermatis, whilst the mycelial phase was named Malassezia furfur. In 1986, the synonomy of these organisms was recognized and the name M. furfur formally accepted for the lipiddependent organisms [7] . In 1990, Simmons & Gueho described a new species, M. sympodialis, isolated from an AIDS patient suffering from tinea capitis [29] . Variations in the colonial morphology and characteristics of isolates of 'M. furfur' led to the description of Fig. 1 The colonial morphologies of the common species of Malassezia as seen when grown on Leeming and Notman agar at 348C for 7 days three serovars [30] and the continued recognition of different forms of the organism by several groups [31, 32] . In an attempt to resolve this confusion, Guillot & Gueho collected representative isolates of all the variants and sequenced the large subunit rRNA and compared the DNA/DNA reassociation [33] . Their results demonstrated that there were indeed significant differences in the variants and these were sufficient to merit their separation into distinct species. The following year, they described and named 7 species of Malassezia: M. furfur, M. sympodialis, M. obtusa, M. globosa, M. restricta, M. slooffiae and M. pachydermatis [34] . Interestingly, in their initial work five new species were differentiated, although only four of them were subsequently named, hinting at the possibility that other species existed. Subsequently, other species of Malassezia have been described, including M. dermatis [35] , M. japonica [36] , M. nana [37] , M. yamotoensis [38] , and M. equi although the latter has not been formally recognized as a species [25] . The changes in taxonomy make comparison of current and previous studies difficult, although Table 1 defines the relationship between old and new classifications, as far as is  currently possible. Many molecular methods have now been developed to examine the taxonomy of the genus and most have confirmed the presence of seven distinct species corresponding to those described by Guillot [33] and more recently the 11 species currently recognised in the genus [39] . Methods such as karyotyping [40] ; sequencing of the chitin synthase 2 gene [41] , the large subunit (LSU) of mitochondrial rRNA [42] , the LSU of the rDNA or the ITS region [43] ; PCR of the LSU of rRNA and digestion with restriction enzymes [44] ; amplified fragment length polymorphism and denaturing gradient gel electrophoresis [45] have all defined seven genetically distinct groups. Several studies have also found that within a currently accepted species there are subgroups (2 [40] , 4 [45] or 8 [43] in M. furfur; 4 in M. sympodialis [27] ; 4 in M. pachydermatis [26] ) and it is likely that this variation within the species may result in the separation of some of the variants and the creation of new species in the future.
Culture, identification and preservation of Malassezia species
Despite many earlier attempts, the first successful culture of Malassezia is thought to have been achieved by Panja in 1927 [46] . The recognition that an external source of lipid was required paved the way for the development of specific media to recover the organism. Many media have been described and they use a range of lipid sources. The simplest medium is Sabouraud's agar overlaid with sterile olive oil, but this medium does not allow enumeration of colonies or detailed examination as the colonies tend to coalesce. Several other media, including Dixon's medium, (containing Tween 40 and glycerol mono-oleate, [47] ) and Leeming and Notman agar (containing Tween 60, glycerol and full fat cow's milk, [48] ) have been developed as selective media for Malassezia species. Figure 1 shows the colonial morphology of some of the species of Malassezia on Leeming and Notman agar. Recently with the recognition of new species of Malassezia it has become apparent that some media may be more effective at recovering certain species than others and this selectivity will obviously impact on recovery data reported by different groups. What is also apparent is that, as yet, there is still no single medium that is able to reliably recover and maintain all the species of Malassezia described so far.
When the re-classification of the Malassezia genus occurred in 1996, sequencing of the large subunit [35] Á M. japonica [36] Á M. nana [37] Á M. yamotoensis [38] Á (M. equi [25] ) Á rRNA and DNA/DNA reassociations were used, but biochemical methods were subsequently published [49] . These were largely based on the micromorphology of the yeasts and the ability of the species to use different Tweens as lipid sources. Since then, modifications and additions to the biochemical methods have been reported that allow better differentiation between similar species. The characteristics of the 11 currently recognized species of Malassezia and their reactions in the various identification tests are detailed in Table 2 .
The most recent method developed for identification of Malassezia species is a bead suspension array that uses species and group specific probes analysed by flow cytometry [50] . The system was initially developed using pure cultures of all 12 currently known species and an unnamed species and is now being modified to detect species direct from clinical material. However, due to its complexity and expense it is unlikely to be useful in a routine setting.
Although identification of Malassezia species can be performed, it is important to consider is when it is appropriate to do so. For most routine clinical mycology laboratories there is little need to speciate the isolates that may be recovered from superficial samples. Although it is of epidemiological interest to determine the species of Malassezia associated with diseases, this is beyond the scope of most laboratories in a routine clinical setting. For pityriasis versicolor, the microscopic appearance is pathognomonic, and isolation of Malassezia per se does not confirm the diagnosis of any of the conditions with which it is associated. However, for samples from sterile and deep sites, culture and identification should be performed.
Because of the time it takes to culture Malassezia (5 Á14 days, dependent on the species) and the realization that no single medium can reliably recover all the species, several groups have developed methods for the molecular analysis of Malassezia directly from the skin without prior culture. Gaitanis et al . [51] took skin scales from 11 patients (with seborrhoeic dermatitis or pityriasis versicolor), extracted the DNA and used PCR and RFLP analysis to determine the species present. Five of the samples yielded DNA; M. restricta and M. sympodialis were detected in the samples from patients with seborrhoeic dermatitis and M. globosa was detected from the patients with pityriasis versicolor. In a similar study of 49 patients with pityriasis versicolor, M. globosa and M. restricta were detected from 94% of patients, with other species detected in less than 35% of patients [52] . In another non-culture based study of the scalp flora of patients with dandruff, swabs were taken from the scalps of 70 patients, DNA extracted directly and terminal fragment length polymorphism analysis involving fluorescent nested PCR of the ITS1and ITS2 region performed [53] . M. restricta and M. globosa were found to be the most prevalent species. M. obtusa and M. slooffiae were found less commonly and M. furfur and M. pachydermatis were not detected in any patient. A study using real time PCR to analyse the lesional flora of 34 patients with atopic eczema/dermatitis syndrome (AEDS) produced a similar spectrum of species, with M. globosa and M. restricta detected most commonly, with higher population densities on the head and neck than on the trunk or limbs [54] . Thus molecular methods, despite removing the need to culture Malassezia species have produced largely similar results to previous culturebased studies, which also found M. sympodialis, M. globosa and M. restricta to be the commonest species found on human skin [55] . Most recently, the Malassezia species present on psoriatic lesions were found not to differ from those on normal skin [56] . The quest to associate particular species of Malassezia with a specific disease has been pursued using many different methods and by many different groups. Although some groups have suggested an association, most studies have shown broadly similar species on healthy and diseased skin. Currently, we do not know whether the pattern of species on healthy skin changes temporally or varies between sites over time, so studies that take a 'snapshot' of the flora at a given time are unlikely to reveal the whole picture. In both culture and nonculture based studies, it is essential that robust sampling methods are used, as the results are only as representative as the collection of the initial sample allows.
One of the problems associated with working with Malassezia is the difficulty of preserving isolates, with certain species being particularly fastidious. In general, M. sympodialis, M. pachydermatis and M. furfur tend to remain viable during storage, whilst M. globosa, M. restricta and M. obtusa are very difficult to maintain in vitro [34] . Crespo et al . carried out a study examining different preservation methods and found that storage at -808C was the most reliable method [57] , with a final assessment of viability at 18 months after preservation. However, only four strains of the most fastidious species were included and results for 'lipiddependent' species were reported together, so it is likely there are variations in survival between the different species not detected in this study.
Commensalism
Malassezia species form part of the normal cutaneous commensal flora of humans and animals. In humans The figures for the predominant species are highlighted in bold.
-2007 ISHAM, Medical Mycology, 45, 287 Á303 they are associated with the sebum-rich areas of the body, including the trunk and the head region, with population densities peaking between 20Á45 years [58] . Many studies have looked at the distribution of the recently defined species on normal skin, and conflicting results have emerged, with different species predominating in different countries. Table 3 summarizes the species isolated from different body sites in different countries. Although these differences may be partly explained by the sampling methods and culture media used, there are probably genuine geographical variations, with the effects of ethnicity and differing diets reflected in the predominance of different species on the skin of individuals in different parts of the world. The species most commonly detected on normal human skin are M. sympodialis, M. globosa and M. restricta , regardless of the culture medium used, the method of sample collection, or the country of study.
Malassezia-associated disease in humans
Malassezia has been associated with a range of cutaneous and systemic diseases, including pityriasis versicolor, seborrhoeic dermatitis, folliculitis, atopic eczema/dermatitis syndrome (AEDS), catheter-related fungaemia, peritonitis and meningitis [59] (Table 4) . Pityriasis versicolor presents as scaly hypo-or hyperpigmented lesions usually on the trunk and back of affected individuals [60] , although in extensive disease lesions may occur on almost any body site. The disease occurs mainly in adults aged 20 Á50 years, is more common in tropical climates and recurs frequently due to the commensal nature of Malassezia . Microscopic examination of scrapings from lesions demonstrates a characteristic 'spaghetti and meatballs' appearance, with both yeast and hyphal forms present due to the phase transition from yeast to mycelium seen in this disease. Many explanations have been suggested for the pigmentary changes in pityriasis versicolor lesions, including the production of azelaic acid and several tryptophan metabolites by Malassezia which can interfere with melanization, but as yet the exact mechanism remains uncertain. Studies of the flora on lesions has yielded conflicting results, with some authors stating that M. globosa is the causative species [61, 62] , whilst others have found M. sympodialis to predominate [63] (see Table 4 ). As with the studies on normal skin, sampling methods and the culture media used for these studies will influence the species recovered and hence may affect the results.
Seborrhoeic dermatitis (SD) is an inflammatory condition occurring on the scalp, face and trunk in around 2 Á5% of the healthy population, but in up to 70 Á80% of patients with untreated AIDS [64] . It is a chronic condition with exacerbations often triggered by stress and dry environments. The improvement of SD (and the related condition, dandruff) by treatments directed against Malassezia supports the role of the yeast in these conditions, although other factors such as impaired barrier function are also thought to be important [65] . The densities of Malassezia present on lesion and non-lesional skin have been studied with some groups finding increased densities on lesions [66] , whilst others found no difference [55, 67, 68] . The species of Malassezia associated with the lesions have also been examined and a complex picture has emerged with M. restricta, M. globosa, M. furfur, M. sympodialis and M. obtusa all recovered from significant numbers of patients in different studies [53,69 Á72 ] (see Table 4 ). Recently, it was shown that application of oleic acid to the scalps of susceptible individuals induced flaking similar to dandruff [73] suggesting that the pathogenesis of SD is multifactorial and that there is no simple relationship either between the number of Malassezia present or the particular species and initiation of disease.
Folliculitis associated with Malassezia was first reported in 1969 in a patient taking tetracycline [74] . The condition presents as follicular papules and pustules surrounded with an erythematous area, occurring on the trunk, neck and face. Since 1969 it has been described in various patient groups, including adults in an intensive care unit [75] ; bone marrow [76] , heart [77] and renal [78] transplant recipients; pregnant women [79, 80] ; patients with AIDS [81] , Hodgkins disease [82] and Down's syndrome [83] . M. restricta and M. globosa have been reported to be associated with folliculitis in a study of 20 patients in Korea [84] .
AEDS is a multifactorial skin disease where chronic inflammation is triggered by various allergens and undergoes cycles of exacerbation and remission [85] . Micro-organisms of the cutaneous flora are known to contribute to these exacerbations in many patients and two lines of evidence implicate Malassezia in the inflammation and exacerbations associated with AEDS. Firstly, AEDS lesions of the head and neck region improve after antifungal therapy. In 1983, Clemmensen and Hjorth found that patients experienced improvement of their disease after 4 weeks oral therapy with ketoconazole [86] , a finding which many subsequent studies have confirmed [87 Á91 ]. The second line of evidence is that AEDS patients have increased sensitisation to Malassezia compared to normal individuals (See section on 'Interaction of Malassezia with the host immune system'). Studies to determine which species of Malassezia might be involved in Table 4 ). The population densities of Malassezia on lesional AEDS skin are decreased compared to non lesional AEDS or normal skin [94] and this is likely to be due to the lower skin lipid content in patients with AEDS [95] , which will reduce the amount of lipid to support the growth of Malassezia species. Malassezia species have also been implicated in a range of other cutaneous diseases, including acne [96] , confluent and reticulated papillomatosis [97] , psoriasis [98] , nodular hair infections [99] , onychomycosis [100] and seborrhoeic blepharitis [101] . However, the evidence linking Malassezia to these conditions is circumstantial, so a definite causal relationship cannot be assumed.
As well as causing superficial disease, Malassezia species are also the causative agents of several deepseated and systemic infections which have generally occurred in patients with underlying disease or predisposing factors. Mastitis [102] , sinusitis [103] , septic arthritis [104] , malignant otitis externa [105] , abscesses [106] and peritonitis in continuous ambulatory peritoneal dialysis patients [107 Á110 ] have all been reported. The most widely reported systemic infection, however, is catheter-related fungaemia in premature neonates. First reported in 1981 [111] , there are now over 100 cases in the literature both in neonates and adults, usually associated with the administration of total parenteral nutrition through central venous catheters. Malassezia colonises the catheter, becoming embedded in a biofilm that seeds organisms into the blood, from where it gains access to the organs, including the lungs and brain resulting in pulmonary vasculitis [111] or meningitis [112] . Removal of the catheter is often the only intervention required to treat fungaemia [113] . Many molecular studies have examined the strains recovered from patients with fungaemia to determine the source of the infection. In some studies strains of M. pachydermatis have been transmitted on the hands of health care workers from their animals [114, 115] , but in other studies no obvious source has been found [116, 117] .
For several of these unusual infections, the isolation of Malassezia and hence the diagnosis may be complicated by the organism's lipid dependent nature as most routinely used mycological media do not support its growth. Use of lipid supplemented media may be warranted in certain specimens, especially if cultures appear 'sterile' on routine media and yeasts have been observed on microscopy. The patient group in whom this may be most appropriate are neonates receiving intravenous nutrition containing high concentrations of lipids when delivered through central venous lines. Supplementation of blood culture bottles with palmitic acid has been shown to improve recovery of Malassezia in this patient group [118] . It has been suggested that there is an association with a specific genotypic subgroup of M. furfur and systemic disease in humans, however this initial study included limited numbers of isolates and needs to be substantiated by larger studies [45] .
Malassezia-associated disease in animals
In addition to causing disease in humans, Malassezia species are the causative agents of several diseases in animals (reviewed in [119, 120] ). Malassezia dermatitis in dogs has been widely studied and presents as pruritic, erythematous lesions, resembling those of AEDS in humans, and usually affecting the abdomen [119] . The condition has been shown to respond to antifungal therapy, suggesting that the yeasts present on the skin of dogs may be involved in the disease. Otitis externa in dogs has also been associated with Malassezia , particularly M. pachydermatis. In both dermatitis and otitis, dogs affected often have atopic tendencies, which may be significant in the development of these conditions. Infections have also been reported in cats, ferrets, pigs, sea lions, horses, bears and the Indian rhinoceros [119] .
Susceptibility of Malassezia species to antifungals
Cutaneous diseases associated with Malassezia are usually treated topically with antifungals, although in cases of extensive disease, systemic antifungal therapy may be required. Many antifungals have been used in a variety of regimens and there are also many studies of the in vitro susceptibility patterns of the different species, which are summarized in Table 5 . Albaconazole and ketoconazole have very good in vitro activity against all species tested, and itraconazole also has generally good activity. All the species tested to date are resistant to flucytosine and for other agents the activity varies with the species and sometimes between different isolates of the same species.
Whatever regimen is used, the problem of recurrence is common in patients with pityriasis versicolor, seborrhoeic dermatitis and AEDS. Recurrence occurs because Malassezia is present on the skin as a commensal and so removal even with extensive antifungal therapy is not a realistic aim and patients should be warned of the relapsing nature of these conditions.
In catheter-related fungaemia, removal of the catheter and discontinuation of the parenteral lipid is often sufficient without antifungal therapy, but amphotericin B or fluconazole have been used, although some fluconazole resistance isolates have been reported [113] . Malassezia species appear to be resistant to flucytosine, at least in vitro so this agent should not be used.
Interaction of Malassezia with the host immune system
The way in which Malassezia interacts with the host immune system is, in many ways, paradoxical. It has the ability to stimulate the immune system via the classical [121] and alternative [122, 123] complement pathways, it acts as an adjuvant [124, 125] and elicits both humoral [126] and cellular [127] immune responses in healthy individuals and also individuals with conditions associated with Malassezia species. In contrast, it is able to resist phagocytic killing by neutrophils [128] and downregulate cytokine responses when co-cultured with peripheral blood mononuclear cells (PBMC) [129] . These apparently contradictory behaviours may be related to the lipid-rich capsular-like layer that surrounds the yeast cells [9] . Removal of the capsular-like layer reverses the suppression of cytokine production by PBMC [130] , however, it is of more relevance to determine whether the same effect occurs when Malassezia is co-cultured with keratinocytes. In [95] and under these conditions, it is likely that Malassezia yeasts present on lesions will have a thinner or absent capsule with a resultant increase in the inflammatory potential of the organism. The interaction of Malassezia with keratinocytes and dendritic cells has recently been reviewed [133] and will not be covered in more detail here.
The exact role that Malassezia plays in the immunopathogenesis of AEDS has been studied intensively over the last 10 years and our understanding of this has advanced markedly. Patients with AEDS have significantly more sensitisation to Malassezia than healthy controls as demonstrated by (i) increased type I hypersensitivity to Malassezia [134] ; (ii) increased prevalence of Malassezia -specific IgE [135, 136] ; (iii) Malassezia -specific Th 2 response [137] ; and, (iv) induction of eczematous lesions after contact with Malassezia [138] . Kosonen et al . [139] have demonstrated that in AEDS patients there is a correlation between the in vitro measurement of Malassezia -specific IgE and the in vivo measurement using skin prick tests, however, neither of these correlated with the severity of disease or outcome with antifungal therapy. It has been postulated that AEDS patients may develop autoreactivity to human proteins and that the antigens which initiate this autoreactivity are microbial antigens that exhibit molecular mimicry. Two antigens described in M. sympodialis, designated Mala s 6 and Mala s 11, show significant sequence homology to human proteins, namely cyclophilins and manganese superoxide dismutase (MnSOD) [140 Á142] . Patients with reactivity to human MnSOD have been shown to have crossreactivity to an extract from M. sympodialis, which was thought to contain Mala s 11, so this antigen from Malassezia may trigger reactivity to human MnSOD by a process of molecular mimicry and so contribute to the exacerbation of lesions in AEDS [143] . Another line of evidence indicating a role for Malassezia in AEDS is the finding that atopy patch testing with Malassezia extracts elicits eczematous reactions, with a predominantly Th 2 -type cytokine response [144, 145] . In a recent large study of 97 patients with AEDS and 571 patients with other forms of allergic reaction or atopy, M. sympodialis specific IgE reactions were found almost exclusively in the AEDS patients [146] . The study used M. sympodialis specific IgE to the ImmunoCap m70 antigen, atopy patch tests, skin prick tests and lymphocyte transformation assays and found positive reactivity in the tests only occurred in patients with either extrinsic or intrinsic atopic eczema, prompting the authors to suggest that these tests should be used as part of the diagnostic workup for these conditions. IgE to the m70 antigen is more commonly positive in adults in whom the AEDS is ongoing, compared with adults in whom the disease is resolved [147] . Other antigens present in M. sympodialis are also recognized by the immune system and are thought to be important in AEDS, and although one has been crystallized, Mala s 1, its function is as yet unknown [148] . The skin of patients with AEDS has a slightly higher pH than normal skin and when grown under similar conditions in vitro M. sympodialis produced and released more antigens, which may exacerbate the inflammation these antigens elicit [149] if similar effects occur in vitro.
Antimicrobial peptides are important components of the non-specific immune system and several are present in human skin, including b-defensins, LL37 (a cathelicidin), dermcidin and psoriasin [150] . LL37, magainin, PR-39 and cecropin P1 have been shown to have activity against Malassezia yeasts, with MICs in the range 20 Á30 mM [151] . LL37 expression is upregulated in keratinocytes that are cultured in the presence of Malassezia cells and in vivo in patients with pityriasis versicolor, LL37 expression is also increased, suggesting that this peptide is involved in the host response against the yeast. In patients with AEDS, levels of LL37 and b-defensins are deficient in the lesions [152] , however, when monocyte derived dendritic cells from patients with severe AEDS are co-cultured with M. sympodialis, higher levels of LL37 were induced compared to less severe AEDS or normal individuals [153] . This suggests that in normal healthy skin production of LL37 is limited, allowing Malassezia to exist as a commensal. However, some upregulation occurs in pityriasis versicolor, in an attempt to eradicate the yeast, but in AEDS levels become so high that they lead to detrimental effects and sustained inflammation in the lesions.
Toll-like receptors (TLR) are a family of proteins involved in microbial recognition during non-specific immune responses via pathogen-associated molecular patterns (PAMPs) [154] . TLR2 and 4 are involved in recognition of C. albicans and A. fumigatus and activation of TLR's can lead to release of b-defensins. Co-culture of normal human keratinocytes with M. furfur increases gene expression of TLR2, MyD88 (a protein of the signalling pathway triggered by TLR2), human b defensin 2 (HBD2) and IL8 and the induction of IL8 and HBD2 is dependent on TLR2 [155] . Thus, this is one mechanism by which Malassezia can induce inflammation via the innate immune system in the skin.
In conclusion, it is now apparent that although the genus Malassezia currently contains 11 species, genetic variation within some species may lead to the description of new species as further molecular studies are performed. Recent work on the interaction of Malassezia spp. and the host, especially in AEDS, demonstrate that far from being an 'innocent bystander' the organisms play a significant role in the initiation and maintenance of inflammation in several cutaneous diseases. The distribution of species on normal skin and in disease shows significant variation and currently the evidence is not conclusive that any given species is responsible for a specific disease. Rather, the situation is complex with particular host predispositions and yeast properties interacting dynamically to result in disease. As our understanding of these interactions increase, it may allow us to control or even prevent these diseases in the future.
